Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Operating expenses:
Research and development	$ 1,168	$ 1,118	$ 3,948	$ 3,058
General and administrative	1,632	1,335	4,247	3,929
Total operating expenses	2,800	2,453	8,195	6,987
Operating loss	(2,800)	(2,453)	(8,195)	(6,987)
Other income:
Interest income	45	1	57	3
Other income		1	9	1
Interest and other income, net	45	2	66	4
Net loss	$ (2,755)	$ (2,451)	$ (8,129)	$ (6,983)
Net loss per share, basic	$ (1.98)	$ (1.79)	$ (5.88)	$ (5.47)
Net loss per share, diluted	$ (1.98)	$ (1.79)	$ (5.88)	$ (5.47)
Weighted average number of common shares outstanding, basic (In Shares)	1,391,481	1,370,851	1,382,118	1,275,682
Weighted average number of common shares outstanding, diluted (In Shares)	1,391,481	1,370,851	1,382,118	1,275,682